Biotechnology
Biopharmaceutical
Pharmaceutical

Ziopharm Oncology

$5.48
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.17 (-3.01%) Today
$0.00 (0.00%) As of 4:08 PM EDT after-hours

Why Robinhood?

You can buy or sell ZIOP and other stocks, options, ETFs, and crypto commission-free!

About ZIOP

ZIOPHARM Oncology Inc Common Stock, also called Ziopharm Oncology, is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of a diverse portfolio of cancer therapies. It focuses on developing products in immuno-oncology that employ novel gene expression, control, and cell technologies for the treatment of cancer. Read More The company was founded on September 9, 2003 and is headquartered in Boston, MA.

CEO
Employees
48
Headquarters
Boston, Massachusetts
Founded
2003
Market Cap
889.33M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
1.00M
High Today
$5.71
Low Today
$5.46
Open Price
$5.64
Volume
1.05M
52 Week High
$6.30
52 Week Low
$1.56

Collections

Biotechnology
Biopharmaceutical
Pharmaceutical
Cancer Prevention
Health
Therapy
Technology
US

ZIOP Earnings

-$0.15
-$0.13
-$0.10
-$0.08
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 8, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.